Time for a gut check. About 150,000 Americans are diagnosed annually with colorectal cancer, which occurs when cells in the ...

The CDC advises 45- to 75 year olds to get screened for colorectal cancer regularly. However, the American Cancer Society's statistics show that it is on the rise among people under the age of 50, ...

Old drugs from Bristol Myers Squibb and Pfizer have delivered what the companies and researchers believe could establish them ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

Barry Stein had ignored symptoms that started appearing in 1995, until he was diagnosed with stage four colorectal cancer.

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

In response to this concerning trend, the US Preventive Services Task Force updated its colorectal cancer screening ...

Metastatic colorectal cancer with microsatellite instability-high or mismatch repair-deficient status represents a distinct ...

Pfizer (PFE) colorectal cancer therapy Braftovi as part of a drug combo indicates a favorable objective response rate in a ...

Bristol Myers Squibb (NYSE:BMY) announced Saturday that its checkpoint inhibitors Opdivo and Yervoy, when combined, reduced the risk of disease progression or death by 38% in a Phase 3 trial for ...

Study of 107,000 participants demonstrates regular aspirin use significantly reduces colorectal cancer risk, especially in ...